Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-miR-191 and promotes the epithelial-to- mesenchymal transition in hepatocellular carcinoma

Neoplasia

Volumn 13, Issue 9, 2011, Pages 841-853

  He, Yinghua ^a   Cui, Ying ^b   Wang, Wei ^a   Gu, Jun ^a   Guo, Shicheng ^a   Ma, Kelong ^a   Luo, Xiaoying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Guangxi Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELL MARKER; DNA; MICRORNA; MICRORNA 191; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LIVER CELL CARCINOMA; MESENCHYME CELL; MOLECULAR MECHANICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UPREGULATION;

EID: 80053435478     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11698     Document Type: Article

References (48)

1. El-Serag HB and Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576.
2. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, and Thorgeirsson SS (2007). Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117, 2713-2722.
3. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, and Nakao A (2007). Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 97, 1260-1265.
4. Morgan TR, Mandayam S, and Jamal MM (2004). Alcohol and hepatocellular carcinoma. Gastroenterology 127, S87-S96.
5. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
6. He L and Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531.
7. Calin GA and Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866.
8. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et al. (2008). Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68, 5049-5058.
9. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, and Inazawa J (2010). miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776.
10. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, et al. (2007). A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 13, 7296-7304.
11. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, and Zhuang SM (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29, 2126-2131.
12. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, Zheng H, Yu J, Wu H, Sun J, et al. (2010). The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 8, e1000533.
13. Xiang H, Zhu J, Chen Q, Dai F, Li X, Li M, Zhang H, Zhang G, Li D, Dong Y, et al. (2010). Single base-resolution methylome of the silkworm reveals a sparse epigenomic map. Nat Biotechnol 28, 516-520.
14. Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M, and Jacobsen SE (2008). Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452, 215-219.
15. Lister R, O'Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, and Ecker JR (2008). Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133, 523-536.
16. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770.
17. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, et al. (2006). DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38, 1378-1385.
18. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Graf S, Johnson N, Herrero J, Tomazou EM, et al. (2008). A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26, 779-785.
19. Winter J, Jung S, Keller S, Gregory RI, and Diederichs S (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11, 228-234.
20. Grinchuk OV, Jenjaroenpun P, Orlov YL, Zhou J, and Kuznetsov VA (2010). Integrative analysis of the human cis-antisense gene pairs, miRNAs and their transcription regulation patterns. Nucleic Acids Res 38, 534-547.
21. Cowden Dahl KD, Dahl R, Kruichak JN, and Hudson LG (2009). The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11, 1208-1215.
22. Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, Xu R, and Huang W (2010). miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52, 2148-2157.
23. Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W, and Bai C (2010). 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol Rep 23, 121-128.
24. Elyakim E, Sitbon E, Faerman A, Tabak S, Montia E, Belanis L, Dov A, Marcusson EG, Bennett CF, Chajut A, et al. (2010). hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res 70, 8077-8087.
25. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, and De Flora S (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23, 806-812.
26. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, Larsson C, and Lui WO (2010). MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130, 2062-2070.
27. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, et al. (2008). MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183-3189.
28. Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et al. (2009). Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 89, 597-606.
29. Kent OA, Mullendore M, Wentzel EA, Lopez-Romero P, Tan AC, Alvarez H, West K, Ochs MF, Hidalgo M, Arking DE, et al. (2009). A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther 8, 2013-2024.
30. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sanudo A, Dall'Oglio MF, Camara-Lopes LH, and Srougi M (2011). MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol 185, 1118-1122.
31. Shen J, DiCioccio R, Odunsi K, Lele SB, and Zhao H (2010). Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer 10, 47.
32. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, and Kornmann M (2006). Prognostic values of microRNAs in colorectal cancer. Biomark Insights 2, 113-121.
33. Wynendaele J, Bohnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, et al. (2010). An illegitimate microRNA target site within the 3′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res 70, 9641-9649.
34. Sengupta S, Kim KS, Berk MP, Oates R, Escobar P, Belinson J, Li W, Lindner DJ, Williams B, and Xu Y (2007). Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene 26, 2894-2901.
35. Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, et al. (2009). miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509.
36. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, and Krichevsky AM (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28, 5369-5380.
37. Koli K, Ryynanen MJ, and Keski-Oja J (2008). Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells. Bone 43, 679-688.
38. Chandramouli A, Simundza J, Pinderhughes A, and Cowin P (2011). Choreographing metastasis to the tune of LTBP. J Mammary Gland Biol Neoplasia 16, 67-80.
39. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, et al. (2003). Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 278, 40967-40972.
40. Piper M, Barry G, Hawkins J, Mason S, Lindwall C, Little E, Sarkar A, Smith AG, Moldrich RX, Boyle GM, et al. (2010). NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1. J Neurosci 30, 9127-9139.
41. Starnes LM, Sorrentino A, Ferracin M, Negrini M, Pelosi E, Nervi C, and Peschle C (2010). A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells. Leukemia 24, 1220-1223.
42. Song HR, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, and Erdreich-Epstein A (2010). Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro Oncol 12, 122-132.
43. Tsunedomi R, Ogawa Y, Iizuka N, Sakamoto K, Tamesa T, Moribe T, and Oka M (2010). The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma. Int J Oncol 36, 205-212.
44. Hartl M, Nist A, Khan MI, Valovka T, and Bister K (2009). Inhibition of Mycinduced cell transformation by brain acid-soluble protein 1 (BASP1). Proc Natl Acad Sci USA 106, 5604-5609.
45. Green LM, Wagner KJ, Campbell HA, Addison K, and Roberts SG (2009). Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation. Nucleic Acids Res 37, 431-440.
46. Soutar AK (2011). Unexpected roles for PCSK9 in lipid metabolism. Curr Opin Lipidol 22, 192-196.
47. Reiche J, Theilig F, Rafiqi FH, Carlo AS, Militz D, Mutig K, Todiras M, Christensen EI, Ellison DH, Bader M, et al. (2010). SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2. Mol Cell Biol 30, 3027-3037.
48. Cizkova M, Cizeron-Clairac G, Vacher S, Susini A, Andrieu C, Lidereau R, and Bieche I (2010). Gene expression profiling reveals new aspects of PIK3CA mutation in ERα-positive breast cancer: major implication of the Wnt signaling pathway. PLoS One 5, e15647.